[Clinical forms of chronic ischemic heart disease]

[Hemodynamic changes in ischemic heart disease with disordered intraventricular conduction].

Vutreshni bolesti·1981

[Clinical trial of the preparation clofazolin used intravenously].

Vutreshni bolesti·1978

[Cardiac output, blood gas analysis and the acid-base state of the blood in chronic cor pulmonale].

Vutreshni bolesti·1977

[Changes in hemodynamics in acute myocardial infarct following administration of potassium orotate].

Vutreshni bolesti·1976

[Aneurysm of the pulmonary artery].

Vutreshni bolesti·1975

[Diagnostic value of the electrocardiographic changes during bicycle ergometer loading].

Vutreshni bolesti·1975

[Comparative analysis of blood and urinary electrolytes in normotensive and hypertensive normal, overweight and obese subjects aged 50-54 in the Bulgarian army].

Vutreshni bolesti·2002

[Studies on restraint ulcers in rats in conditions of acute copper deficiency].

Vutreshni bolesti·2002

[Congestive heart failure--some current problems].

Vutreshni bolesti·2002

[Antioxidant parameters in metabolic syndrome -- a dynamic evaluation during oral glucose tolerance test].

Vutreshni bolesti·2002

[Interleukins and endocrine function].

Vutreshni bolesti·2002

[Longitudinal study of parameters of respiratory function tests and blood gas analysis in patients with progressive systemic scleroderma].

Vutreshni bolesti·2002

Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.

Rheumatology (Oxford, England)·2026

Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy.

The British journal of radiology·2026

Myocardial Calcification After Severe Sepsis: 3-Patient Case Series, Multimodality Imaging, and Review of the Literature.

JACC. Case reports·2026

One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.

Molecular medicine reports·2026

BIOCARD framework: integrating fecal bile acids, lipids, and metabolites to assess response to a cardiovascular health intervention.

Gut microbes·2026

Related Experiment Videos

[Clinical forms of chronic ischemic heart disease]

Related Concept Videos

[Hemodynamic changes in ischemic heart disease with disordered intraventricular conduction].

[Clinical trial of the preparation clofazolin used intravenously].

[Cardiac output, blood gas analysis and the acid-base state of the blood in chronic cor pulmonale].

[Changes in hemodynamics in acute myocardial infarct following administration of potassium orotate].

[Aneurysm of the pulmonary artery].

[Diagnostic value of the electrocardiographic changes during bicycle ergometer loading].

[Comparative analysis of blood and urinary electrolytes in normotensive and hypertensive normal, overweight and obese subjects aged 50-54 in the Bulgarian army].

[Studies on restraint ulcers in rats in conditions of acute copper deficiency].

[Congestive heart failure--some current problems].

[Antioxidant parameters in metabolic syndrome -- a dynamic evaluation during oral glucose tolerance test].

[Interleukins and endocrine function].

[Longitudinal study of parameters of respiratory function tests and blood gas analysis in patients with progressive systemic scleroderma].

Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.

Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy.

Myocardial Calcification After Severe Sepsis: 3-Patient Case Series, Multimodality Imaging, and Review of the Literature.

One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.

Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.

BIOCARD framework: integrating fecal bile acids, lipids, and metabolites to assess response to a cardiovascular health intervention.

Related Experiment Videos

[Clinical forms of chronic ischemic heart disease]

Related Concept Videos

Related Articles